Clear Street’s Ibere Pharmaceuticals IBER Stock Holding History

Clear Street's IBER Position: Q1 2023 in Review

Clear Street sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 1,543 shares — an estimated $16K sold.

Clear Street first reported a position in IBER in Q4 2022 and held it in 1 quarter. The position peaked at $16K in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

• Clear Street reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
• Clear Street sold 1,543 Ibere Pharmaceuticals shares in Q1 2023, an estimated $16K.
• Clear Street first reported a position in Ibere Pharmaceuticals in Q4 2022 and held it in 1 quarter.
• Clear Street's Ibere Pharmaceuticals position peaked at $16K in Q4 2022.
• 0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Clear Street's 13F filing for Q1 2023, filed 12 May 2023.